{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T07:29:12Z","timestamp":1779348552347,"version":"3.51.4"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T00:00:00Z","timestamp":1523491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0195828","type":"journal-article","created":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T18:24:30Z","timestamp":1523557470000},"page":"e0195828","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Urinary cGMP predicts major adverse renal events in patients with mild renal impairment and\/or diabetes mellitus before exposure to contrast medium"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6250-4007","authenticated-orcid":true,"given":"Lyubov","family":"Chaykovska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Heunisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gina","family":"von Einem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl-Friedrich","family":"Hocher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleg","family":"Tsuprykov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mira","family":"Pavkovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Sandner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Kretschmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saban","family":"Elitok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes-Peter","family":"Stasch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berthold","family":"Hocher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,4,12]]},"reference":[{"issue":"9","key":"ref1","doi-asserted-by":"crossref","first-page":"RA199","DOI":"10.12659\/MSM.881923","article-title":"Contrast-induced nephropathy\u2014a review of current literature and guidelines","volume":"17","author":"A Maliborski","year":"2011","journal-title":"Med Sci Monit"},{"issue":"10","key":"ref2","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3109\/08860220903216113","article-title":"Urinary and serum biomarkers after cardiac catheterization in diabetic patients with stable angina and without severe chronic kidney disease","volume":"31","author":"J Malyszko","year":"2009","journal-title":"Ren Fail"},{"issue":"10","key":"ref3","first-page":"1332","article-title":"The Prevention of Contrast-Induced Nephropathy","volume":"48","author":"TH Au","journal-title":"Ann Pharmacother"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4065\/79.2.211","article-title":"Contrast nephropathy after coronary angiography","volume":"79","author":"AS Gami","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"ref5","first-page":"362725","article-title":"Acute Kidney Injury by Radiographic Contrast Media: Pathogenesis and Prevention","author":"M Andreucci","year":"2014","journal-title":"Biomed Res Int"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4196\/kjpp.2011.15.5.273","article-title":"Altered Regulation of Renal Nitric Oxide and Atrial Natriuretic Peptide Systems in Lipopolysaccharide-induced Kidney Injury","volume":"15","author":"EH Bae","journal-title":"Korean J Physiol Pharmacol"},{"issue":"17","key":"ref7","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/BF01726575","article-title":"Atrial natriuretic peptide in human urine","volume":"66","author":"K Ando","year":"1988","journal-title":"Klin Wochenschr"},{"issue":"9","key":"ref8","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1093\/clinchem\/36.9.1650","article-title":"Concentrations of atrial natriuretic peptide in plasma and urine of kidney disease patients","volume":"36","author":"F Marumo","year":"1990","journal-title":"Clin Chem"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1161\/HYPERTENSIONAHA.113.01344","article-title":"Atrial natriuretic peptide genetic variant rs5065 and risk for cardiovascular disease in the general community: a 9-year follow-up study","volume":"62","author":"V Cannone","journal-title":"Hypertension"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.molmet.2016.12.010","article-title":"Divergent effects of a designer natriuretic peptide CD-NP in the regulation of adipose tissue and metabolism","volume":"6","author":"A Glode","journal-title":"Mol Metab"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2478\/ams-2013-0006","article-title":"Renal function after percutaneous coronary interventions depending on the type of hydration","volume":"58","author":"IT Jarocka","year":"2013","journal-title":"Adv Med Sci"},{"key":"ref12","first-page":"362725","article-title":"Acute kidney injury by radiographic contrast media: pathogenesis and prevention","volume":"2014","author":"M Andreucci","year":"2014","journal-title":"Biomed Res Int"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4196\/kjpp.2011.15.5.273","article-title":"Altered Regulation of Renal Nitric Oxide and Atrial Natriuretic Peptide Systems in Lipopolysaccharide-induced Kidney Injury","volume":"15","author":"EH Bae","year":"2011","journal-title":"Korean J Physiol Pharmacol"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.pharmthera.2009.02.009","article-title":"Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics","volume":"122","author":"EJ Tsai","year":"2009","journal-title":"Pharmacol Ther"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/01.CIR.90.2.823","article-title":"Plasma arteriovenous cGMP difference as a useful indicator of nitrate tolerance in patients with heart failure","volume":"90","author":"T Tsutamoto","year":"1994","journal-title":"Circulation"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/clinchem\/37.2.186","article-title":"Release of cyclic guanosine monophosphate evaluated as a diagnostic tool in cardiac diseases","volume":"37","author":"KP Vorderwinkler","year":"1991","journal-title":"Clin Chem"},{"issue":"14","key":"ref17","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/BF01647578","article-title":"Effects of a small bolus dose of ANF in healthy volunteers and in patients with volume retaining disorders","volume":"68","author":"JM Heim","year":"1990","journal-title":"Klin Wochenschr"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/s-2007-1000788","article-title":"On the relation of atrial natriuretic peptide and cyclic guanosine 3',5'-monophosphate plasma concentrations during ergometric exercise in healthy individuals","volume":"26","author":"G Jakob","year":"1994","journal-title":"Horm Metab Res"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/clinchem\/40.1.96","article-title":"Clinical significance of urinary cyclic guanosine monophosphate in diagnosis of heart failure","volume":"40","author":"G Jakob","year":"1994","journal-title":"Clin Chem"},{"issue":"Suppl 1","key":"ref20","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1186\/1471-2210-7-S1-S14","article-title":"Modulating cGMP in heart failure","volume":"7","author":"J Burnett","year":"2007","journal-title":"BMC Pharmacology"},{"issue":"9","key":"ref21","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1161\/ATVBAHA.115.306133","article-title":"Cyclic GMP in Vascular Relaxation: Export Is of Similar Importance as Degradation","volume":"35","author":"C Krawutschke","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"ref22","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1161\/01.CIR.97.12.1209","article-title":"Is measurement of cyclic guanosine monophosphate in plasma or urine suitable for assessing in vivo nitric oxide production?","volume":"97","author":"J Mair","year":"1998","journal-title":"Circulation"},{"issue":"Suppl 2","key":"ref23","first-page":"41","article-title":"Is cyclic GMP a clinically useful marker for ANF action?","volume":"77","author":"JM Heim","year":"1988","journal-title":"Z Kardiol"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"e0145723","DOI":"10.1371\/journal.pone.0145723","article-title":"Urinary Vitamin D Binding Protein and KIM-1 Are Potent New Biomarkers of Major Adverse Renal Events in Patients Undergoing Coronary Angiography","volume":"11","author":"L Chaykovska","journal-title":"PLoS One"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"e6065","DOI":"10.1097\/MD.0000000000006065","article-title":"ADMA predicts major adverse renal events in patients with mild renal impairment and\/or diabetes mellitus undergoing coronary angiography","volume":"96","author":"F Heunisch","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"ref26","first-page":"1393","article-title":"A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation","volume":"44","author":"R Mehran","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"ref27","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"AS Levey","year":"1999","journal-title":"Ann Intern Med"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/sj.bjp.0704483","article-title":"Cardiovascular actions of a novel NO-independent guanylyl cyclase stimulator, BAY 41\u20138543: in vivo studies","volume":"135","author":"JP Stasch","year":"2002","journal-title":"Br J Pharmacol"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/kisup.2012.64","article-title":"Chapter 1: Definition and classification of CKD","volume":"3","year":"2013","journal-title":"Kidney Int Suppl (2011)"},{"key":"ref30","first-page":"5","article-title":"World Health Organ Tech Rep Ser","volume":"405","year":"1968","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"5","key":"ref31","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/ki.2012.451","article-title":"Nephrologist follow-up improves all-cause mortality of severe acute kidney injury survivors","volume":"83","author":"Z Harel","journal-title":"Kidney Int"},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/CCM.0000000000000042","article-title":"The association between renal replacement therapy modality and long-term outcomes among critically ill adults with acute kidney injury: a retrospective cohort study*","volume":"42","author":"R Wald","journal-title":"Crit Care Med"},{"key":"ref33","first-page":"22","article-title":"The assessment, serial evaluation, and subsequent sequelae of acute kidney injury (ASSESS-AKI) study: design and methods","volume":"11","author":"AS Go","journal-title":"BMC Nephrol"},{"issue":"11","key":"ref34","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.2337\/diabetes.50.11.2603","article-title":"Effect of diabetes on nitric oxide metabolism during cardiac surgery","volume":"50","author":"BM Matata","year":"2001","journal-title":"Diabetes"},{"key":"ref35","first-page":"837421","article-title":"Hypoxia in diabetic kidneys","author":"Y Takiyama","year":"2014","journal-title":"Biomed Res Int"},{"issue":"7","key":"ref36","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/ki.2008.350","article-title":"Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics","volume":"74","author":"LG Fine","year":"2008","journal-title":"Kidney Int"},{"issue":"Pt 1","key":"ref37","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1469-7793.1997.243bo.x","article-title":"The effects of chronic hypoxia on renal function in the rat","volume":"501","author":"M Neylon","year":"1997","journal-title":"J Physiol"},{"issue":"5","key":"ref38","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1161\/HYPERTENSIONAHA.106.083832","article-title":"Targeting heme-oxidized soluble guanylate cyclase in experimental heart failure","volume":"49","author":"G Boerrigter","year":"2007","journal-title":"Hypertension"},{"issue":"6","key":"ref39","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1161\/01.HYP.19.6.775","article-title":"Nitric oxide alters renal function and guanosine 3',5'-cyclic monophosphate","volume":"19","author":"HM Siragy","year":"1992","journal-title":"Hypertension"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ijcard.2016.11.019","article-title":"Association of contrast-induced nephropathy with risk of adverse clinical outcomes in patients with cardiac catheterization: From the CINC-J study","volume":"227","author":"A Sato","year":"2017","journal-title":"Int J Cardiol"},{"issue":"6","key":"ref41","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1038\/ki.1995.220","article-title":"Zaprinast accelerates recovery from established acute renal failure in the rat","volume":"47","author":"Z Guan","year":"1995","journal-title":"Kidney Int"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"F167","DOI":"10.1152\/ajprenal.00197.2005","article-title":"Enhancing cGMP in experimental progressive renal fibrosis: soluble guanylate cyclase stimulation vs. phosphodiesterase inhibition","volume":"290","author":"Y Wang","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"ref43","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/j.1476-5381.2010.01149.x","article-title":"Sildenafil, a phosphodiesterase type 5 inhibitor, attenuates diabetic nephropathy in non-insulin-dependent Otsuka Long-Evans Tokushima Fatty rats","volume":"162","author":"Y Kuno","journal-title":"Br J Pharmacol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.coph.2014.12.014","article-title":"Renal effects of soluble guanylate cyclase stimulators and activators: a review of the preclinical evidence","volume":"21","author":"JP Stasch","journal-title":"Curr Opin Pharmacol"},{"issue":"5","key":"ref45","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1111\/j.1523-1755.2005.00669.x","article-title":"Early treatment with cGMP phosphodiesterase inhibitor ameliorates progression of renal damage","volume":"68","author":"B Rodriguez-Iturbe","year":"2005","journal-title":"Kidney Int"},{"issue":"6","key":"ref46","first-page":"F1220","article-title":"Urinary cGMP as biological marker of the renal activity of atrial natriuretic factor","volume":"255","author":"KR Wong","year":"1988","journal-title":"Am J Physiol"},{"issue":"6","key":"ref47","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1046\/j.1523-1755.1998.00217.x","article-title":"Temporal relationships between hormonal and hemodynamic changes in early human pregnancy","volume":"54","author":"AB Chapman","year":"1998","journal-title":"Kidney Int"},{"issue":"1","key":"ref48","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1172\/JCI107534","article-title":"Plasma clearance rates and renal clearance of 3H-labeled cyclic AMP and 3H-labeled cyclic GMP in the dog","volume":"53","author":"L Blonde","year":"1974","journal-title":"J Clin Invest"},{"issue":"12","key":"ref49","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1172\/JCI106441","article-title":"Kinetic parameters and renal clearances of plasma adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in man","volume":"49","author":"AE Broadus","year":"1970","journal-title":"J Clin Invest"},{"issue":"6","key":"ref50","doi-asserted-by":"crossref","first-page":"e000536","DOI":"10.1161\/JAHA.113.000536","article-title":"The cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fraction","volume":"2","author":"SJ Greene","journal-title":"J Am Heart Assoc"},{"issue":"19","key":"ref51","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1161\/01.CIR.97.19.1921","article-title":"Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction","volume":"97","author":"AM Richards","year":"1998","journal-title":"Circulation"},{"issue":"3","key":"ref52","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00134-018-5126-8","article-title":"Biomarkers for prediction of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis","volume":"44","author":"SJ Klein","year":"2018","journal-title":"Intensive Care Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0195828","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T17:03:25Z","timestamp":1604163805000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0195828"}},"subtitle":[],"editor":[{"given":"Tatsuo","family":"Shimosawa","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,4,12]]},"references-count":52,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0195828","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,12]]}}}